Unlock The Brain: Invest In Tokenized Neuroscience IP
Neuroscience IP is now being tokenized as real-world assets (RWAs). Blockchain enables fractional ownership of patents on neural algorithms, fMRI datasets, and drug discovery models. Smart contracts legally secure and tokenize this IP. ERC-721/1155 standards issue tokens representing fractional ownership (e.g., 0.001%). Chainlink oracles verify IP usage. Royalties are automatically distributed via on-chain logic. IP undergoes auditing for novelty and utility. Discounted cash flow (DCF) models are utilized for valuation. Deployment occurs on Ethereum L2s (Optimism) for scalability. DAO governance manages decision-making. Compliance is achieved through Reg D wrappers for accredited investors. 2026 pilots show $300M tokenized neuro IP volume. Capital raises are 35% faster ($1.8M avg/project). A 28% liquidity premium exists vs. traditional IP sales. Examples include tokenized synaptic plasticity models and fractional Alzheimer's biomarker patents. Tokenized neuro IP unlocks brain research, allowing investors to purchase fractions of patents. This fuels AI-drug discovery and collaborative mind-mapping. https://www.ainvest.com/news/ip-rwa-big-tokenization-trend-2601